BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38229877)

  • 21. A Network Perspective on Neuropsychiatric and Cognitive Symptoms of the Post-COVID Syndrome.
    Scharfenberg D; Schild AK; Warnke C; Maier F
    Eur J Psychol; 2022 Nov; 18(4):350-356. PubMed ID: 36605094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses.
    Needham EJ; Ren AL; Digby RJ; Norton EJ; Ebrahimi S; Outtrim JG; Chatfield DA; Manktelow AE; Leibowitz MM; Newcombe VFJ; Doffinger R; Barcenas-Morales G; Fonseca C; Taussig MJ; Burnstein RM; Samanta RJ; Dunai C; Sithole N; Ashton NJ; Zetterberg H; Gisslén M; Edén A; Marklund E; Openshaw PJM; Dunning J; Griffiths MJ; Cavanagh J; Breen G; Irani SR; Elmer A; Kingston N; Summers C; Bradley JR; Taams LS; Michael BD; Bullmore ET; Smith KGC; Lyons PA; Coles AJ; Menon DK; ; ;
    Brain; 2022 Nov; 145(11):4097-4107. PubMed ID: 36065116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up.
    Gramaglia C; Gattoni E; Gambaro E; Bellan M; Balbo PE; Baricich A; Sainaghi PP; Pirisi M; Binda V; Feggi A; Jona A; Marangon D; Prosperini P; Zeppegno P
    Front Psychiatry; 2022; 13():862651. PubMed ID: 35782424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No evidence for neuronal damage or astrocytic activation in cerebrospinal fluid of Neuro-COVID-19 patients with long-term persistent headache.
    de Boni L; Odainic A; Gancarczyk N; Kaluza L; Strassburg CP; Kersting XAK; Wüllner U; Schmidt SV; Petzold GC
    Neurol Res Pract; 2023 Sep; 5(1):49. PubMed ID: 37759276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovering from COVID-19: psychological sequelae and post-traumatic growth six months after discharge.
    Bonazza F; Luridiana Battistini C; Fior G; Bergamelli E; Wiedenmann F; D'Agostino A; Sferrazza Papa GF; Borghi L; Piscopo K; Vegni E; Lamiani G
    Eur J Psychotraumatol; 2022; 13(1):2095133. PubMed ID: 35903268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurological Involvement in COVID-19 Among Non-Hospitalized Adolescents and Young Adults.
    Havdal LB; Berven LL; Selvakumar J; Stiansen-Sonerud T; Leegaard TM; Tjade T; Zetterberg H; Blennow K; Wyller VBB
    Front Neurol; 2022; 13():915712. PubMed ID: 35812102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Huang C; Huang L; Wang Y; Li X; Ren L; Gu X; Kang L; Guo L; Liu M; Zhou X; Luo J; Huang Z; Tu S; Zhao Y; Chen L; Xu D; Li Y; Li C; Peng L; Li Y; Xie W; Cui D; Shang L; Fan G; Xu J; Wang G; Wang Y; Zhong J; Wang C; Wang J; Zhang D; Cao B
    Lancet; 2021 Jan; 397(10270):220-232. PubMed ID: 33428867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive inhibition deficit in long COVID-19: An exploratory study.
    Saucier J; Jose C; Beroual Z; Al-Qadi M; Chartrand S; Libert E; Losier MC; Cooling K; Girouard G; Jbilou J; Chamard-Witkowski L
    Front Neurol; 2023; 14():1125574. PubMed ID: 37122293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depressive and Anxiety Symptoms in Severe COVID-19 Survivors: A Prospective Cohort Study.
    Martins S; Ferreira AR; Fernandes J; Vieira T; Fontes L; Coimbra I; Paiva JA; Fernandes L
    Psychiatr Q; 2022 Sep; 93(3):891-903. PubMed ID: 35947293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.
    Kanberg N; Ashton NJ; Andersson LM; Yilmaz A; Lindh M; Nilsson S; Price RW; Blennow K; Zetterberg H; Gisslén M
    Neurology; 2020 Sep; 95(12):e1754-e1759. PubMed ID: 32546655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium.
    de Erausquin GA; Snyder H; Brugha TS; Seshadri S; Carrillo M; Sagar R; Huang Y; Newton C; Tartaglia C; Teunissen C; Håkanson K; Akinyemi R; Prasad K; D'Avossa G; Gonzalez-Aleman G; Hosseini A; Vavougios GD; Sachdev P; Bankart J; Mors NPO; Lipton R; Katz M; Fox PT; Katshu MZ; Iyengar MS; Weinstein G; Sohrabi HR; Jenkins R; Stein DJ; Hugon J; Mavreas V; Blangero J; Cruchaga C; Krishna M; Wadoo O; Becerra R; Zwir I; Longstreth WT; Kroenenberg G; Edison P; Mukaetova-Ladinska E; Staufenberg E; Figueredo-Aguiar M; Yécora A; Vaca F; Zamponi HP; Re VL; Majid A; Sundarakumar J; Gonzalez HM; Geerlings MI; Skoog I; Salmoiraghi A; Boneschi FM; Patel VN; Santos JM; Arroyo GR; Moreno AC; Felix P; Gallo C; Arai H; Yamada M; Iwatsubo T; Sharma M; Chakraborty N; Ferreccio C; Akena D; Brayne C; Maestre G; Blangero SW; Brusco LI; Siddarth P; Hughes TM; Zuñiga AR; Kambeitz J; Laza AR; Allen N; Panos S; Merrill D; Ibáñez A; Tsuang D; Valishvili N; Shrestha S; Wang S; Padma V; Anstey KJ; Ravindrdanath V; Blennow K; Mullins P; Łojek E; Pria A; Mosley TH; Gowland P; Girard TD; Bowtell R; Vahidy FS
    Alzheimers Dement (N Y); 2022; 8(1):e12348. PubMed ID: 36185993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
    ; Morin L; Savale L; Pham T; Colle R; Figueiredo S; Harrois A; Gasnier M; Lecoq AL; Meyrignac O; Noel N; Baudry E; Bellin MF; Beurnier A; Choucha W; Corruble E; Dortet L; Hardy-Leger I; Radiguer F; Sportouch S; Verny C; Wyplosz B; Zaidan M; Becquemont L; Montani D; Monnet X
    JAMA; 2021 Apr; 325(15):1525-1534. PubMed ID: 33729425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: A 9-month follow-up study.
    Mirfazeli FS; Sarabi-Jamab A; Pereira-Sanchez V; Kordi A; Shariati B; Shariat SV; Bahrami S; Nohesara S; Almasi-Dooghaee M; Faiz SHR
    Neurol Sci; 2022 Apr; 43(4):2231-2239. PubMed ID: 35059902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID-Results from the Prospective Population-Based COVI-GAPP Study.
    Telser J; Grossmann K; Weideli OC; Hillmann D; Aeschbacher S; Wohlwend N; Velez L; Kuhle J; Maleska A; Benkert P; Risch C; Conen D; Risch M; Risch L
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of Neurological Blood-Based Biomarkers in Critically Ill Patients With Coronavirus Disease 2019.
    Cooper J; Stukas S; Hoiland RL; Fergusson NA; Thiara S; Foster D; Mitra A; Stoessl JA; Panenka WJ; Sekhon MS; Wellington CL
    Crit Care Explor; 2020 Oct; 2(10):e0238. PubMed ID: 33063038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19.
    Zingaropoli MA; Pasculli P; Barbato C; Petrella C; Fiore M; Dominelli F; Latronico T; Ciccone F; Antonacci M; Liuzzi GM; Talarico G; Bruno G; Galardo G; Pugliese F; Lichtner M; Mastroianni CM; Minni A; Ciardi MR
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759493
    [No Abstract]   [Full Text] [Related]  

  • 38. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
    Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
    J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.